Fig. 2.
Treatment with anti-MCH antibody attenuates established TNBS colitis. Starting at day 3 post-TNBS exposure, after colitis had been established, mice received daily injections of anti-MCH or control antibody for a total of four doses. The severity of colitis was assessed by measuring colon length (A) and scoring colonic macroscopic inflammation (B) and microscopic inflammation (C). *, p < 0.05 compared to control.
